Virpax Pharmaceuticals(VRPX) - 2021 Q1 - Quarterly Report
Virpax PharmaceuticalsVirpax Pharmaceuticals(US:VRPX)2021-05-17 20:01

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2021 Commission File Number: 001-40064 VIRPAX PHARMACEUTICALS, INC. (Exact name of registrant as specified in the charter) Delaware 82-1510982 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 1055 Westlakes Drive, Suite 300 Berwyn, PA 19312 (Addre ...